A cavernous malformation (also called a cavernoma or cavernous angioma) is a cluster of abnormally enlarged, thin-walled blood vessels within the brain or spinal cord that are prone to repeated small hemorrhages. They have a characteristic "popcorn-like" appearance on MRI and can cause seizures, headaches, and focal neurological deficits depending on their location. Unlike AVMs, cavernous malformations are low-flow lesions that are invisible on conventional angiography — MRI is the only reliable way to detect them.
Cavernous malformations are part of a family of vascular lesions of the brain that includes arteriovenous malformations (AVMs) and brain aneurysms. While all three can cause intracranial hemorrhage and stroke, cavernous malformations have a distinct low-flow biology, a characteristic MRI signature, and a different natural history that requires individualized management. They are among the most common incidental findings on brain MRI.
Causes
Sporadic occurrence
The majority of cavernous malformations occur sporadically with no identifiable cause or family history. They are believed to arise from developmental abnormalities in small cerebral vessel formation. Prior radiation therapy to the brain — whether for childhood brain tumors or other conditions — is a well-established cause of radiation-induced cavernous malformations, which can appear years to decades after treatment.
Familial cavernous malformations
Approximately 20% of cases are familial, caused by autosomal dominant mutations in one of three genes: CCM1 (KRIT1), CCM2, or CCM3. Familial cases are characterized by multiple malformations distributed throughout the brain and spinal cord, which increase in number over a patient's lifetime. They tend to present at younger ages and require systematic surveillance imaging. A specific CCM1 founder mutation is significantly more prevalent in Hispanic Americans of Mexican descent, giving this population a higher prevalence of familial cavernous malformations than the general population.
Symptoms
Many cavernous malformations are discovered incidentally on MRI performed for unrelated reasons such as headaches or head trauma, and cause no symptoms throughout a person's lifetime. When symptomatic, presentations include:
- Seizures: The most common presenting symptom for cortical (supratentorial) lesions — caused by hemosiderin deposition from chronic micro-hemorrhages irritating adjacent brain tissue.
- Acute hemorrhage: Sudden onset of headache and focal neurological deficits corresponding to the lesion's location. While individual bleeding events are rarely as catastrophic as AVM or aneurysm rupture, repeated hemorrhages cause cumulative neurological damage.
- Focal neurological deficits: Weakness, sensory loss, visual disturbances, or cognitive changes from mass effect or ischemia in surrounding tissue.
- Brainstem-specific symptoms: Brainstem cavernous malformations — even small ones — cause disproportionately severe symptoms including double vision (diplopia), facial numbness, swallowing difficulty, and limb weakness due to the extreme concentration of critical neural structures in this compact region. Brainstem lesions carry the highest symptom burden per unit of hemorrhage.
Diagnosis
MRI is the definitive and only reliable imaging modality for cavernous malformations — they are angiographically occult, meaning they cannot be seen on CT angiography or conventional catheter angiography due to their low-flow nature. The classic MRI appearance is a "popcorn" or "mulberry" lesion: a mixed-signal core representing blood products in multiple stages of breakdown (acute, subacute, and chronic hemorrhage), surrounded by a dark hemosiderin rim from prior micro-bleeds.
Susceptibility-weighted imaging (SWI) is the most sensitive MRI sequence for cavernous malformations, detecting tiny lesions invisible on standard sequences by amplifying the signal of hemosiderin and blood degradation products. SWI is particularly important in familial cases, where it reveals the full extent of the lesion burden and guides surveillance. CT scan frequently misses cavernous malformations entirely. When multiple lesions are identified or family history is present, genetic testing for CCM gene mutations is recommended to guide family screening.
Classification
Cavernous malformations are classified by location, which is the primary determinant of symptom severity and treatment threshold:
- Supratentorial (cerebral hemispheres): Most common location. Seizures are the most frequent presenting symptom. Accessible lesions that bleed and cause neurological deficits or refractory seizures are good surgical candidates.
- Infratentorial (brainstem and cerebellum): Higher symptomatic impact per bleed due to eloquent location. Brainstem cavernomas warrant a lower threshold for surgical intervention given the consequences of repeated hemorrhage in this critical region.
- Spinal cord: Rare but can cause progressive myelopathy — loss of motor and sensory function below the lesion — with repeated hemorrhage. Surgical management is considered for accessible lesions causing progressive deficits.
Treatments
Treatment decisions are guided by the lesion's location, history of symptomatic hemorrhage, seizure burden, and the patient's age and surgical risk. The natural history varies significantly — many lesions never bleed symptomatically, while others (particularly brainstem lesions) bleed repeatedly.
Observation:
Asymptomatic or incidentally discovered cavernous malformations are typically managed with periodic MRI surveillance — annually for the first few years, then less frequently if stable. Anti-epileptic medications are prescribed for seizure control and are continued until seizure freedom is established, at which point surgical options may be reconsidered.
Microsurgical resection:
Surgery is the definitive treatment and is recommended for accessible lesions that have caused symptomatic hemorrhage, for medically refractory seizures, or for lesions in locations where further bleeding would cause severe irreversible deficits. Complete resection of the cavernoma and its surrounding hemosiderin ring is curative, permanently eliminating the risk of future hemorrhage from that lesion and improving seizure control in the majority of patients. Intraoperative MRI and neuronavigation are used to maximize safety and completeness of resection.
Stereotactic radiosurgery:
Radiosurgery (Gamma Knife or CyberKnife) may be considered for deep, surgically inaccessible lesions — particularly brainstem cavernomas — with repeated symptomatic hemorrhages where the surgical risk is prohibitive. Its effectiveness in reducing hemorrhage risk is less clearly established than for AVMs, and it carries its own risk of radiation-induced injury. It is reserved for cases where the natural history risk of continued hemorrhage clearly outweighs the treatment risk.
Get an MRI to Confirm Your Diagnosis
Before surgical planning or starting treatment, a clear MRI diagnosis ensures the right path forward. First Look MRI offers self-pay Brain MRI scans — no doctor's order or insurance required — at our locations in Georgia, Texas, and Colorado.